FEATURED
Takaji Matsutani,
Esra Akbay,
Eyad Elkord
Frontiers Media SA
Immune checkpoint inhibitors (ICIs) such as anti-PD-1 and anti-PD-L1 antibodies are highly effective against many types of cancer, yet durable responses are limited to a subset of patients...
Health
Immunology
Cancer Immunity and Immunotherapy
Keywords: Immunotherapy,targeted therapy,Tumor Microenvironment,immune checkpoint inhibitors,Cancer biomarkers,Anti-PD-L1 antibodies